公司概覽
業務類別 Diagnostics & Research
業務概覽 Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ inthe office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
公司地址 One IDEXX Drive, Westbrook, ME, USA, 04092
電話號碼 +1 207 556-0300
傳真號碼 +1 207 556-4346
公司網頁 https://www.idexx.com
員工數量 11000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Michael G. Erickson, PhD Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine -- 13/01/2026
Mr. Andrew J. Emerson Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer -- 20/02/2026
Mr. George J. Fennell Executive Vice President, Global CAG Commercial -- 28/03/2025
Mr. Jonathan J. Mazelsky Director, President and Chief Executive Officer 美元 1.12M 13/01/2026
Dr. Martin Alexander Smith, PhD Executive Vice President, Global Operations and Research and Development 美元 576.64K 28/03/2025
Ms. Sharon E. Underberg Executive Vice President, General Counsel and Corporate Secretary -- 28/03/2025
Mr. Michael J. Lane Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology 美元 576.64K 28/03/2025
Dr. Nimrata Khatra Hunt, PhD Executive Vice President, Global Strategy and Commercial 美元 576.64K 28/03/2025
Mr. Michael Schreck Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience -- 28/03/2025
Mr. Michael P. Johnson Senior Vice President and Chief Human Resources Officer -- 28/03/2025
 
董事會成員
董事會 職務 更新日期
Mr. Bruce L. Claflin Independent Director 20/02/2026
Mr. Daniel M. Junius Independent Director 20/02/2026
Ms. M. Anne Szostak Independent Director 13/02/2026
Mr. Lawrence D. Kingsley Non-Executive Chairman of the Board 20/02/2026
Dr. Sophie V. Vandebroek, PhD Independent Director 20/02/2026
Mr. Stuart M. Essig, PhD Independent Director 20/02/2026
Mr. Jonathan J. Mazelsky Director, President and Chief Executive Officer 13/01/2026
Mr. Sam A. Samad Independent Director 20/02/2026
Mr. Joseph L. Hooley Independent Director 20/02/2026
Ms. Karen A. Peacock Independent Director 20/02/2026
Ms. Irene Chang Britt Independent Director 20/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:18)
代號 名稱 佔比% 持有日期
USXFiShares® ESG Advanced MSCI USA ETF0.01%28/02/2026
CATHGlobal X S&P 500® Catholic Values ETF0.01%27/02/2026
GPIXGoldman Sachs S&P 500 Premium Inc ETF0.01%27/02/2026
GSUSGoldman Sachs MarketBeta US Equity ETF0.01%27/02/2026
PCGGPolen Capital Global Growth ETF0.01%31/12/2025
FRTYAlger Mid Cap 40 ETF0.005%27/02/2026
PRFInvesco RAFI US 1000 ETF0.005%27/02/2026
XHEStt Strt® SPDR® S&P®HlthCrEqpmntETF0.005%27/02/2026
UPROProShares UltraPro S&P5000.005%27/02/2026
VFQYVanguard US Quality Factor ETF0.005%31/12/2025
PTLInspire 500 ETF0.005%27/02/2026
QUSStt Strt® SPDR® MSCI USA StratFacs ETF0.005%27/02/2026
RISNInspire Tactical Balanced ETF0.005%27/02/2026
GSWOGoldman Sachs ActiveBeta World Eq ETF0.005%27/02/2026
SPYXSttStrt® SPDR® S&P®500FsslFulRsrvFreeETF0.004%27/02/2026
IYYiShares Dow Jones US ETF0.004%28/02/2026
DFSUDimensional US Sustainability Core 1 ETF0.004%27/02/2026
SEIMSEI Enhanced US Large Cap Momt Fac ETF0.004%27/02/2026
DSPYTema S&P 500 Hist Wght ETF Strat0.004%27/02/2026
JOETVirtus Terranova US Quality Momentum ETF0.003%27/02/2026
  1    2    3    4    5   6    7    8    9    10    11    12    13    14    15    16  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.